These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Sequential methotrexate, 5-fluorouracil (high-dose), and doxorubicin for advanced gastric cancer. Muro H; Acuña LR; Castagnari A; Blajman C; Schmilovich A; Hidalgo A; Fiori H; Bader M; Marantz A Cancer Treat Rep; 1986 Nov; 70(11):1333-4. PubMed ID: 3768875 [No Abstract] [Full Text] [Related]
5. Medical management of advanced gastric cancer. Hill ME; Cunningham D Cancer Treat Rev; 1998 Apr; 24(2):113-8. PubMed ID: 9728421 [No Abstract] [Full Text] [Related]
7. [Recent advances in chemotherapy for advanced gastric cancer: from the standpoint of survival advantages]. Ohtsu A; Yoshida S; Miyata Y; Shimada Y Gan To Kagaku Ryoho; 1995 Mar; 22(4):444-50. PubMed ID: 7887636 [TBL] [Abstract][Full Text] [Related]
8. [Regarding the article "Adjuvant chemotherapy in gastric cancer. Experience at the National Institute of Nutrition"]. Sulkes A Rev Invest Clin; 1993; 45(1):94. PubMed ID: 8484072 [No Abstract] [Full Text] [Related]
9. [Antineoplastic chemotherapy in digestive tumors]. Bellmunt J; Albanell J; Gallego OS; Vicente P Med Clin (Barc); 1991 Sep; 97(9):358. PubMed ID: 1720494 [No Abstract] [Full Text] [Related]
11. ECF in gastric cancer. Ross PJ; Hill ME; Norman A; Cunningham D J Clin Oncol; 2000 Nov; 18(22):3874-5. PubMed ID: 11078502 [No Abstract] [Full Text] [Related]
12. [A pilot study of combined chemotherapy using methotrexate (MTX), 5-fluorouracil (5-FU) and pirarubicin (THP) for advanced or recurrent gastric cancer]. Yamamura Y; Kodera Y; Kito T Gan To Kagaku Ryoho; 1995 Sep; 22(10):1407-10. PubMed ID: 7668879 [No Abstract] [Full Text] [Related]
13. Chemotherapy of metastatic gastric cancer. Wils J Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():395-8. PubMed ID: 10895185 [No Abstract] [Full Text] [Related]
15. Celiac axis infusion (CAI) chemotherapy for advanced gastric cancer. Aigner KR; Benthin F; Müller H Cancer Treat Res; 1991; 55():357-62. PubMed ID: 1681866 [No Abstract] [Full Text] [Related]
16. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin--a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cooperative Group. Wils JA; Klein HO; Wagener DJ; Bleiberg H; Reis H; Korsten F; Conroy T; Fickers M; Leyvraz S; Buyse M J Clin Oncol; 1991 May; 9(5):827-31. PubMed ID: 2016625 [TBL] [Abstract][Full Text] [Related]
17. [A five-year-survival case in which complete response was recognized after combined chemotherapy using 5-fluorouracil, adriamycin and mitomycin C (FAM) for unresectable gastric cancer]. Iwase K; Takenaka H; Sumimura J; Ishizaka T; Takagaki M; Bessho T; Ohata T; Inoue M; Oshima S; Tanaka T Gan To Kagaku Ryoho; 1992 Nov; 19(13):2235-7. PubMed ID: 1444491 [TBL] [Abstract][Full Text] [Related]
18. An EORTC Gastrointestinal Group evaluation of the combination of sequential methotrexate and 5-fluorouracil, combined with adriamycin in advanced measurable gastric cancer. Wils J; Bleiberg H; Dalesio O; Blijham G; Mulder N; Planting A; Splinter T; Duez N J Clin Oncol; 1986 Dec; 4(12):1799-803. PubMed ID: 3783204 [TBL] [Abstract][Full Text] [Related]